Skip to Main Content

Paper Details

Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge.
Vaccine
21
2012
Author NameAffiliation
Christopher S MorelloDepartment of Cellular and Molecular Medicine University of California
Deborah H SpectorDepartment of Cellular and Molecular Medicine University of California
Deborah H SpectorSkaggs School of Pharmacy and Pharmaceutical Sciences, University of California
  • 1 - 3

Datasets

Release 1.2